No trial has tested weekly doses below 0.25 mg for weight loss, so any efficacy claims about true microdoses are extrapolations, not evidence
However, the full appetite-regulating effects become more noticeable after 2-4 weeks as the body adjusts to the medication
Cannabis, by contrast, is commonly associated with appetite stimulation
Case 1: Increased Breast Density Following the Use of a GLP-1 Agonist A 66-year-old woman with recent history of 65 lb
What documentation supports a clean 90471 claim
What this means for real people For readers wondering whether the science or the price should sway decisions, here is a practical take by experts - If your goal is diabetes control and modest weight loss, semaglutide formulations (Ozempic) remain a mainstream choice, supported by cardiovascular outcomes data and diabetes approvals